ArticleJournal of clinical hypertension (Greenwich, Conn.)2011
Sustained blood pressure control following discontinuation of a pharmacist intervention.
Article in Journal of clinical hypertension (Greenwich, Conn.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Interventions to Improve Medication Adherence in Hypertensive Patients: Systematic Review and Meta-analysis.Current hypertension reports · 2015Pooled it
- Team-based care and improved blood pressure control: a community guide systematic review.American journal of preventive medicine · 2014Pooled it
- Effects of Pharmacist Intervention on Community Control of Hypertension: A Randomized Controlled Trial in Zunyi, China.Global health, science and practice · 2021Trial
- Long-term Outcomes of the Effects of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Among Adults With Uncontrolled Hypertension: Follow-up of a Cluster Randomized Clinical Trial.JAMA network open · 2018Trial
- Sustained Blood Pressure Control Following Discontinuation of a Pharmacist Intervention for Veterans.Journal of clinical hypertension (Greenwich, Conn.) · 2015Trial
- Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control.Circulation. Cardiovascular quality and outcomes · 2015Trial
- Blood pressure 1 year after completion of web-based pharmacist care.JAMA internal medicine · 2013Trial
- Trial
- Incremental costs associated with physician and pharmacist collaboration to improve blood pressure control.Pharmacotherapy · 2012Trial
- Improving refill adherence and hypertension control in black patients: Wisconsin TEAM trial.Journal of the American Pharmacists Association : JAPhATrial
- Team-Based Care for Improving Hypertension Management: A Pragmatic Randomized Controlled Trial.Frontiers in cardiovascular medicine · 2021Article
- Long-term impact of pharmacist intervention in patients with bipolar disorder: extended follow-up to the EMDADER-TAB study.Heliyon · 2020Article
- Translational science matters: forging partnerships between biomedical and behavioral science to advance the public's health.Translational behavioral medicine · 2018Review
- Avoiding Pitfalls With Implementation of Randomized Controlled Multicenter Trials: Strategies to Achieve Milestones.Journal of the American Heart Association · 2016Review
- An integrated general practice and pharmacy-based intervention to promote the use of appropriate preventive medications among individuals at high cardiovascular disease risk: protocol for a cluster randomized controlled trial.Implementation science : IS · 2016Article
- The role of telemedicine in hypertension management: focus on blood pressure telemonitoring.Current hypertension reports · 2015Review
- Characteristics of diabetic patients associated with achieving and maintaining blood pressure targets in the Adherence and Intensification of Medications program.Chronic illness · 2014Article
- Agreement between community pharmacy and ambulatory and home blood pressure measurement methods to assess the effectiveness of antihypertensive treatment: the MEPAFAR study.Journal of clinical hypertension (Greenwich, Conn.) · 2012Article
- The hypertension team: the role of the pharmacist, nurse, and teamwork in hypertension therapy.Journal of clinical hypertension (Greenwich, Conn.) · 2012Review
- Higher Predictive Value Positive for MMA Than ACA MTM Eligibility Criteria Among Racial and Ethnic Minorities: An Observational Study.Inquiry : a journal of medical care organization, provision and financingObservational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Team-based care can improve hypertension control. The purpose of the present study was to evaluate blood pressure (BP) control 18 months following the discontinuation of a physician-pharmacist collaborative intervention. This was a retrospective analysis of patients who had previously participated in a prospective, cluster randomized, controlled clinical trial. Six community-based family medicine offices were randomized to control or intervention groups. Research nurses measured BPs using an automated device during the prospective trial. The research nurses then abstracted data from medical records, including BPs, medications, changes in therapy, and laboratory values for 18 months following the discontinuation of the 6-month prospective trial. The study included 228 patients in the control (n = 146) or intervention (n = 82) groups. The control group contained more patients with diabetes or chronic kidney disease (P < .013), were older (P = .047), and had more coexisting conditions (P < .001) than the intervention group. Systolic BP 9 months following discontinuation of the physician-pharmacist intervention was 137.2 ± 18.2 mm Hg and 129.8 ± 13.3 mm Hg in the control and intervention groups, respectively (P = .0015). BP control was maintained in 61 (41.8%) control patients and 55 (67.1%) intervention patients (P = .0003). At 18 months post-intervention, systolic BP was 138.1 ± 20.4 mm Hg and 130.0 ± 16.0 mm Hg in the control and intervention groups, respectively (P = .023). BP control was maintained in 53 (36.3%) control patients and 55 (67.1%) intervention patients at 18 months post-intervention (P < .0001). A sensitivity analysis was conducted to address the uneven distribution of patients with diabetes or chronic kidney disease, and the differences between groups were still significant. BP control rates remained significantly higher following a physician-pharmacist intervention compared with usual care for 18 months after discontinuation of the intervention. This model has the potential value as a useful long-term strategy to benefit patients with hypertension.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.